Soojin Kim
About Soojin Kim
Soojin Kim serves as the Senior Vice President and Chief Technical Operations Officer at Inozyme Pharma, bringing over 25 years of experience in pharmaceutical research and development. She holds a Ph.D. and an M.S. in chemical engineering from Caltech and has worked in various leadership roles at prominent pharmaceutical companies.
Work at Inozyme
Soojin Kim currently serves as the Senior Vice President and Chief Technical Operations Officer at Inozyme Pharma, a position she has held since 2022. In this role, she oversees the technical operations of the company, focusing on the development and manufacturing processes. Her leadership is integral to advancing Inozyme's mission in the pharmaceutical industry. The company is based in Boston, Massachusetts, where Kim applies her extensive experience in pharmaceutical research and development.
Education and Expertise
Soojin Kim holds a Ph.D. and an M.S. in Chemical Engineering from the California Institute of Technology, where she studied from 1988 to 1994. She also earned a B.S. in Chemical Engineering with distinction from Cornell University, studying from 1984 to 1988. Her educational background provides a strong foundation for her expertise in pharmaceutical research, development, and manufacturing, with over 25 years of experience in the field.
Background
Soojin Kim began her career with a postdoctoral position at The Polytechnic Institute of New York University from 1994 to 1997. She then joined Bristol-Myers Squibb as a Principal Scientist, where she worked for ten years. Following this, she served as a Senior Research Fellow at Boehringer Ingelheim Pharmaceuticals from 2007 to 2015, leading the API development group. Before joining Inozyme, she was the Senior Vice President and site head at Hanmi Pharmaceuticals from 2015 to 2022.
Achievements
Soojin Kim has made significant contributions to the pharmaceutical industry, including publishing approximately 50 journal articles, book chapters, and proceedings. She is also an inventor on more than 20 patents. Her roles have included managing clinical and commercial manufacturing, process and analytical development, and quality management, showcasing her comprehensive expertise in the field.